Annalisa Jenkins

Annalisa Jenkins is a highly experienced executive and board member in the biotechnology and pharmaceutical industries. She recently announced her new position as Non Executive Board Member at Skye Bioscience Inc. on April 7, 2024.2

Professional Experience

Annalisa Jenkins has an extensive career spanning multiple leadership roles:

Current Positions::

• Non Executive Director at several companies, including:

  • Oncimmune (since September 2017)
  • COMPASS Pathways (since March 2018)
  • AVROBIO (since June 2018)
  • Affimed (since August 2020)
  • Mereo BioPharma (since September 2022)
  • Genomics England (since January 2021)1

• Chair of multiple organizations:

  • Cocoon Biotech (since October 2017)
  • Conduit Connect (since November 2019)
  • Phaim Pharma Ltd (since December 2019)
  • RevoluGen Ltd (since May 2022)1

Past Positions::

• President and CEO of Dimension Therapeutics (September 2014 - November 2017)
• Chief Executive Officer of PlaqueTec Ltd. (November 2017 - January 2019)
• Executive Chairman of Vium (January 2016 - August 2020)1

Board Memberships and Advisory Roles

Annalisa Jenkins serves on numerous boards and advisory committees:

• Trustee for the British Heart Foundation and The King's Fund (since April 2022)
• Board Member of FasterCures, a Center of the Milken Institute (since September 2018)
• Managing Director of annalisajenkins LLC (since March 2014)1

Location and Connections

Based in Princeton, New Jersey, United States, Annalisa Jenkins has over 500 connections on LinkedIn.1

Annalisa Jenkins' extensive experience in biotechnology, pharmaceuticals, and healthcare, combined with her numerous board positions, demonstrates her expertise and influence in the life sciences industry.